Chronic Kidney Disease
Chronic Kidney Disease
Part of NephTimes
Advertisement
Ajay K. Singh, MBBS, FRCP, MBAFrom the Chair | July 7, 2025
Editorial board chair Dr. Ajay Singh discusses how GFR may vary between sexes and affect rates of CKD.
Victoria SochaGout | June 27, 2025
Elevated glucose uptake in adipose tissue of patients with gout may contribute to CKD progression.
Charlotte RobinsonChronic Kidney Disease | June 19, 2025
Kidney Care Partners visited called on Congress to support policies benefitting Americans with kidney disease.
Charlotte RobinsonChronic Kidney Disease | June 19, 2025
AstraZeneca and Aptar Digital Health are partnering on screening algorithms to detect CKD and other conditions.
Charlotte RobinsonChronic Kidney Disease | June 26, 2025
Study results suggest that psychosocial interventions effectively reduce depression symptoms in people with CKD.
Charlotte RobinsonChronic Kidney Disease | July 7, 2025
Variability in eGFR over time is associated with risks of cardiovascular and kidney outcomes and mortality in those with CKD.
Charlotte RobinsonChronic Kidney Disease | June 26, 2025
An observational study shed light on how family medical history may affect chronic kidney disease (CKD) outcomes.
Charlotte RobinsonChronic Kidney Disease | June 13, 2025
Fibrate use is associated with higher incidence of CKD but lower risk for ESKD and mortality, a study found.
Charlotte RobinsonChronic Kidney Disease | June 26, 2025
Iron therapy may reduce cardiovascular risks for patients with chronic kidney disease, a study found.
Rajiv Agarwal, MBBSERA Congress 2025 | June 26, 2025
Rajiv Agarwal discussed a study showing that a finerenone-empagliflozin combo has superior efficacy in CKD and T2D.
Charlotte RobinsonERA Congress 2025 | June 11, 2025
Treatment with a finerenone-empagliflozin combo leads to greater decreases in albuminuria in CKD and type 2 diabetes.
Charlotte RobinsonERA Congress 2025 | June 26, 2025
A study highlights the role of NPT2b in tubulointerstitial fibrosis and CKD progression.
Victoria SochaChronic Kidney Disease | July 7, 2025
Finerenone had kidney and cardiovascular benefits for patients with CKD even after an acute eGFR change occurred.
Victoria SochaChronic Kidney Disease | June 26, 2025
A dual SGLT inhibitor may have ischemic benefits for patients with CKD, T2D, and cardiovascular risks, a study found.
Victoria SochaChronic Kidney Disease | June 26, 2025
An analysis of CKD trials supported 3-year total slope as the primary slope-based outcome in randomized trials.
Charlotte RobinsonChronic Kidney Disease | May 14, 2025
Researchers fitted a face mask with a breath sensor that may be able to detect the presence of chronic kidney disease.
Victoria SochaChronic Kidney Disease | June 13, 2025
A meta-analysis examined the risk of CKD in patients with metabolic dysfunction-associated fatty liver disease.
Charlotte RobinsonChronic Kidney Disease | June 26, 2025
Researchers sought to quantify the population at risk for pruritus, clinical determinants, and associated adverse outcomes.
Charlotte RobinsonAcute Kidney Injury | June 26, 2025
A study assessed whether proton pump inhibitor use accelerated CKD progression and acute kidney injury risk.
Melanie Betz, MS, RD, CSR, FNKF, FANDNKF Spring Clinical Meetings 2025 | June 23, 2025
Joel Topf spoke with dietitian Melanie Betz about potassium, oxalate, and other renal nutrition concerns.
Advertisement